Clinical Trial Update: Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing cabazitaxel to docetaxel, both with prednisone, in metastatic castration-resistant prostate cancer; results were posted after completion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Cabazitaxel (cabazitaxel)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-03-03